Relapsing Remitting Multiple Sclerosis: Clinical Trials

1 trial for Relapsing Remitting Multiple Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1

Follow Relapsing Remitting Multiple Sclerosis: new trials by email Literature Review of Relapsing Remitting Multiple Sclerosis trials Research Report on Relapsing Remitting Multiple Sclerosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients
Ritalin - Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis, Chronic Progressive
Phase 1UnknownSheba Medical Center802003-06-012007-01-05

Narrower conditions

Multiple Sclerosis, Chronic Progressive (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Chronic Disease (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Disease Attributes (1)  ·  Immune System Diseases (1)  ·  Multiple Sclerosis (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Methylphenidate (1)

Sponsors

Sheba Medical Center (1)

Countries

Israel (1)

Top investigators

Anat Achiron, MD PhD (1)  ·  Nava Appleboim-Gavish, MA (1)  ·  Yirmiyahu Harel, MD (1)